Rosiglitazone Description

Posted: May 20, 2014 in Best Chemicals

Rosiglitazone is an anti-diabetic biologic in the thiazolidinedione chic of drugs. It is marketed by the biologic aggregation GlaxoSmithKline as a stand-alone biologic (Avandia) and in aggregate with metformin (Avandamet) or with glimepiride (Avandaryl). Like added thiazolidinediones, the apparatus of activity of rosiglitazone is by activation of the intracellular receptor chic of the peroxisome proliferator-activated receptors (PPARs), accurately PPARγ. Rosiglitazone is a careful ligand of PPARγ, and has no PPARα-binding action. Apart from its aftereffect on insulin resistance, it appears to accept an anti-inflammatory effect: nuclear agency kappa-B (NFκB) levels abatement and inhibitor (IκB) levels access in patients on rosiglitazone. Recent analysis has appropriate that rosiglitazone may aswell be of account to a subset of patients with Alzheimer’s ache not cogent the ApoE4 allele. This is the accountable of a analytic balloon currently underway.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s